MedTrace Logo

Estrogen Hormone Products

NCT05645406 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-11-10

No results posted yet for this study

Summary

The purpose is to determine if the two estradiol products can deliver similar amounts of estradiol after single and multiple dosing.

Conditions

Interventions

DRUG

Divigel 0.1% Topical Gel

estradiol topical products

DRUG

Compounded estradiol product

estradiol topical products

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Audra Stinchcomb, PhD · University of Maryland, Baltimore

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-14
Primary Completion
2025-06-12
Completion
2025-06-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05645406 on ClinicalTrials.gov